J, S., S, R., Q, Z., J, H., Y, W., & M, R. (2025). Endostatin-based anti-angiogenic therapy and immune modulation: Mechanisms and synergistic potential in cancer treatment. Frontiers in immunology, 16, 1623859. https://doi.org/10.3389/fimmu.2025.1623859
Chicago Style (17th ed.) CitationJ, Sun, Ren S, Zhao Q, He J, Wang Y, and Ren M. "Endostatin-based Anti-angiogenic Therapy and Immune Modulation: Mechanisms and Synergistic Potential in Cancer Treatment." Frontiers in Immunology 16 (2025): 1623859. https://doi.org/10.3389/fimmu.2025.1623859.
MLA (9th ed.) CitationJ, Sun, et al. "Endostatin-based Anti-angiogenic Therapy and Immune Modulation: Mechanisms and Synergistic Potential in Cancer Treatment." Frontiers in Immunology, vol. 16, 2025, p. 1623859, https://doi.org/10.3389/fimmu.2025.1623859.